Incidence of chronic renal injury in patients undergoing autologous stem cell transplant therapy
C Dawson, E Palfreyman, R Parisotto… - Internal Medicine …, 2023 - Wiley Online Library
Background Haemopoietic stem cell transplant (HSCT) is a well‐established treatment
option for many haematologic immunologic and oncologic diseases, allowing the safe …
option for many haematologic immunologic and oncologic diseases, allowing the safe …
The incidence of chronic renal injury in patients undergoing autologous stem cell transplant therapy.
C Dawson, E Palfreyman, R Parisotto… - Internal Medicine …, 2022 - europepmc.org
Background Haematopoietic stem cell transplant (HSCT) is a well-established treatment
option for many haematologic immunologic and oncologic diseases, allowing the safe …
option for many haematologic immunologic and oncologic diseases, allowing the safe …
Incidence of chronic renal injury in patients undergoing autologous stem cell transplant therapy
C Dawson, E Palfreyman… - Internal medicine …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Haemopoietic stem cell transplant (HSCT) is a well-established treatment
option for many haematologic immunologic and oncologic diseases, allowing the safe …
option for many haematologic immunologic and oncologic diseases, allowing the safe …